vs

Side-by-side financial comparison of Option Care Health, Inc. (OPCH) and Roper Technologies (ROP). Click either name above to swap in a different company.

Roper Technologies is the larger business by last-quarter revenue ($2.1B vs $1.5B, roughly 1.4× Option Care Health, Inc.). Roper Technologies runs the higher net margin — 15.8% vs 4.0%, a 11.8% gap on every dollar of revenue. On growth, Roper Technologies posted the faster year-over-year revenue change (11.3% vs 8.8%). Over the past eight quarters, Option Care Health, Inc.'s revenue compounded faster (13.1% CAGR vs 10.5%).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

OPCH vs ROP — Head-to-Head

Bigger by revenue
ROP
ROP
1.4× larger
ROP
$2.1B
$1.5B
OPCH
Growing faster (revenue YoY)
ROP
ROP
+2.4% gap
ROP
11.3%
8.8%
OPCH
Higher net margin
ROP
ROP
11.8% more per $
ROP
15.8%
4.0%
OPCH
Faster 2-yr revenue CAGR
OPCH
OPCH
Annualised
OPCH
13.1%
10.5%
ROP

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
OPCH
OPCH
ROP
ROP
Revenue
$1.5B
$2.1B
Net Profit
$58.5M
$331.0M
Gross Margin
19.3%
69.4%
Operating Margin
6.2%
27.2%
Net Margin
4.0%
15.8%
Revenue YoY
8.8%
11.3%
Net Profit YoY
-2.7%
53.7%
EPS (diluted)
$0.37
$4.87

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPCH
OPCH
ROP
ROP
Q1 26
$2.1B
Q4 25
$1.5B
$2.1B
Q3 25
$1.4B
$2.0B
Q2 25
$1.4B
$1.9B
Q1 25
$1.3B
$1.9B
Q4 24
$1.3B
$1.9B
Q3 24
$1.3B
$1.8B
Q2 24
$1.2B
$1.7B
Net Profit
OPCH
OPCH
ROP
ROP
Q1 26
$331.0M
Q4 25
$58.5M
$428.4M
Q3 25
$51.8M
$398.5M
Q2 25
$50.5M
$378.3M
Q1 25
$46.7M
$331.1M
Q4 24
$60.1M
$462.3M
Q3 24
$53.9M
$367.9M
Q2 24
$53.0M
$337.1M
Gross Margin
OPCH
OPCH
ROP
ROP
Q1 26
69.4%
Q4 25
19.3%
69.5%
Q3 25
19.0%
69.5%
Q2 25
19.0%
69.2%
Q1 25
19.7%
68.7%
Q4 24
21.3%
68.3%
Q3 24
20.1%
69.2%
Q2 24
20.3%
69.5%
Operating Margin
OPCH
OPCH
ROP
ROP
Q1 26
27.2%
Q4 25
6.2%
28.6%
Q3 25
5.9%
28.4%
Q2 25
5.8%
28.2%
Q1 25
5.9%
27.9%
Q4 24
6.9%
28.0%
Q3 24
6.7%
28.1%
Q2 24
6.6%
28.8%
Net Margin
OPCH
OPCH
ROP
ROP
Q1 26
15.8%
Q4 25
4.0%
20.8%
Q3 25
3.6%
19.8%
Q2 25
3.6%
19.5%
Q1 25
3.5%
17.6%
Q4 24
4.8%
24.6%
Q3 24
4.2%
20.8%
Q2 24
4.3%
19.6%
EPS (diluted)
OPCH
OPCH
ROP
ROP
Q1 26
$4.87
Q4 25
$0.37
$3.97
Q3 25
$0.32
$3.68
Q2 25
$0.31
$3.49
Q1 25
$0.28
$3.06
Q4 24
$0.36
$4.29
Q3 24
$0.31
$3.40
Q2 24
$0.30
$3.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPCH
OPCH
ROP
ROP
Cash + ST InvestmentsLiquidity on hand
$232.6M
$382.9M
Total DebtLower is stronger
$9.7B
Stockholders' EquityBook value
$1.3B
$18.8B
Total Assets
$3.5B
$34.6B
Debt / EquityLower = less leverage
0.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPCH
OPCH
ROP
ROP
Q1 26
$382.9M
Q4 25
$232.6M
$297.4M
Q3 25
$309.8M
$320.0M
Q2 25
$198.8M
$242.4M
Q1 25
$171.4M
$372.8M
Q4 24
$412.6M
$188.2M
Q3 24
$483.0M
$269.6M
Q2 24
$376.9M
$251.5M
Total Debt
OPCH
OPCH
ROP
ROP
Q1 26
$9.7B
Q4 25
$9.3B
Q3 25
$1.2B
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.1B
$7.6B
Q3 24
$1.1B
Q2 24
$1.1B
Stockholders' Equity
OPCH
OPCH
ROP
ROP
Q1 26
$18.8B
Q4 25
$1.3B
$19.9B
Q3 25
$1.4B
$20.0B
Q2 25
$1.4B
$19.6B
Q1 25
$1.4B
$19.2B
Q4 24
$1.4B
$18.9B
Q3 24
$1.4B
$18.5B
Q2 24
$1.4B
$18.1B
Total Assets
OPCH
OPCH
ROP
ROP
Q1 26
$34.6B
Q4 25
$3.5B
$34.6B
Q3 25
$3.5B
$34.6B
Q2 25
$3.4B
$33.2B
Q1 25
$3.3B
$31.4B
Q4 24
$3.4B
$31.3B
Q3 24
$3.4B
$31.6B
Q2 24
$3.3B
$29.8B
Debt / Equity
OPCH
OPCH
ROP
ROP
Q1 26
0.52×
Q4 25
0.47×
Q3 25
0.86×
Q2 25
0.82×
Q1 25
0.82×
Q4 24
0.79×
0.40×
Q3 24
0.78×
Q2 24
0.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPCH
OPCH
ROP
ROP
Operating Cash FlowLast quarter
$258.4M
Free Cash FlowOCF − Capex
$507.0M
FCF MarginFCF / Revenue
24.2%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
4.42×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPCH
OPCH
ROP
ROP
Q1 26
Q4 25
$258.4M
$738.0M
Q3 25
$139.4M
$869.5M
Q2 25
$90.3M
$404.1M
Q1 25
$-7.2M
$528.7M
Q4 24
$36.1M
$722.2M
Q3 24
$160.4M
$755.4M
Q2 24
$195.7M
$384.1M
Free Cash Flow
OPCH
OPCH
ROP
ROP
Q1 26
$507.0M
Q4 25
Q3 25
$130.2M
Q2 25
$81.2M
Q1 25
$-16.6M
Q4 24
$25.8M
Q3 24
$150.7M
Q2 24
$185.9M
FCF Margin
OPCH
OPCH
ROP
ROP
Q1 26
24.2%
Q4 25
Q3 25
9.1%
Q2 25
5.7%
Q1 25
-1.2%
Q4 24
2.0%
Q3 24
11.8%
Q2 24
15.1%
Capex Intensity
OPCH
OPCH
ROP
ROP
Q1 26
0.5%
Q4 25
Q3 25
0.6%
Q2 25
0.6%
Q1 25
0.7%
Q4 24
0.8%
Q3 24
0.8%
Q2 24
0.8%
Cash Conversion
OPCH
OPCH
ROP
ROP
Q1 26
Q4 25
4.42×
1.72×
Q3 25
2.69×
2.18×
Q2 25
1.79×
1.07×
Q1 25
-0.15×
1.60×
Q4 24
0.60×
1.56×
Q3 24
2.98×
2.05×
Q2 24
3.69×
1.14×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons